- Home
- PET vs ADXN Comparison
PET vs ADXN Comparison
Compare PET & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- ADXN
- Stock Information
- Founded
- PET 2015
- ADXN 2002
- Country
- PET United States
- ADXN Switzerland
- Employees
- PET N/A
- ADXN N/A
- Industry
- PET EDP Services
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- PET Technology
- ADXN Health Care
- Exchange
- PET Nasdaq
- ADXN Nasdaq
- Market Cap
- PET 7.4M
- ADXN 8.1M
- IPO Year
- PET N/A
- ADXN N/A
- Fundamental
- Price
- PET $0.14
- ADXN $10.23
- Analyst Decision
- PET Strong Buy
- ADXN Strong Buy
- Analyst Count
- PET 4
- ADXN 1
- Target Price
- PET $4.13
- ADXN $30.00
- AVG Volume (30 Days)
- PET 2.1M
- ADXN 1.4K
- Earning Date
- PET 05-12-2025
- ADXN 06-17-2025
- Dividend Yield
- PET N/A
- ADXN N/A
- EPS Growth
- PET N/A
- ADXN N/A
- EPS
- PET N/A
- ADXN 0.08
- Revenue
- PET $62,453,000.00
- ADXN $452,495.00
- Revenue This Year
- PET $7.87
- ADXN $86.57
- Revenue Next Year
- PET $122.23
- ADXN N/A
- P/E Ratio
- PET N/A
- ADXN $0.88
- Revenue Growth
- PET N/A
- ADXN N/A
- 52 Week Low
- PET $0.08
- ADXN $6.51
- 52 Week High
- PET $1.79
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- PET 46.08
- ADXN 73.57
- Support Level
- PET $0.14
- ADXN $8.08
- Resistance Level
- PET $0.17
- ADXN $8.20
- Average True Range (ATR)
- PET 0.01
- ADXN 0.23
- MACD
- PET 0.00
- ADXN 0.11
- Stochastic Oscillator
- PET 21.89
- ADXN 71.04
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.